Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Operating Expenses (2024 - 2025)

Historic Operating Expenses for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $1.5 million.

  • Kairos Pharma's Operating Expenses rose 55585.59% to $1.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $2.3 million for FY2024, which is 3669.78% up from last year.
  • As of Q2 2025, Kairos Pharma's Operating Expenses stood at $1.5 million, which was up 55585.59% from $1.3 million recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Operating Expenses ranged from a high of $1.5 million in Q2 2025 and a low of $222000.0 during Q2 2024